Literature DB >> 17033691

Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms.

Hwa Kyoung Shin1, Salvatore Salomone, E Michelle Potts, Sae-Won Lee, Eric Millican, Kensuke Noma, Paul L Huang, David A Boas, James K Liao, Michael A Moskowitz, Cenk Ayata.   

Abstract

Rho-kinase is a serine threonine kinase that increases vasomotor tone via its effects on both endothelium and smooth muscle. Rho-kinase inhibition reduces cerebral infarct size in wild type, but not endothelial nitric oxide synthase deficient (eNOS-/-) mice. The mechanism may be related to Rho-kinase activation under hypoxic/ischemic conditions and impaired vasodilation because of downregulation of eNOS activity. To further implicate Rho-kinase in impaired vascular relaxation during hypoxia/ischemia, we exposed isolated vessels from rat and mouse to 60 mins of hypoxia, and showed that hypoxia reversibly abolished acetylcholine-induced eNOS-dependent relaxation, and that Rho-kinase inhibitor hydroxyfasudil partially preserved this relaxation during hypoxia. We, therefore, hypothesized that if hypoxia-induced Rho-kinase activation acutely impairs vasodilation in ischemic cortex, in vivo, then Rho-kinase inhibitors would acutely augment cerebral blood flow (CBF) as a mechanism by which they reduce infarct size. To test this, we studied the acute cerebral hemodynamic effects of Rho-kinase inhibitors in ischemic core and penumbra during distal middle cerebral artery occlusion (dMCAO) in wild-type and eNOS-/- mice using laser speckle flowmetry. When administered 60 mins before or immediately after dMCAO, Rho-kinase inhibitors hydroxyfasudil and Y-27632 reduced the area of severely ischemic cortex. However, hydroxyfasudil did not reduce the area of CBF deficit in eNOS-/- mice, suggesting that its effect on CBF within the ischemic cortex is primarily endothelium-dependent, and not mediated by its direct vasodilator effect on vascular smooth muscle. Our results suggest that Rho-kinase negatively regulates eNOS activity in acutely ischemic brain, thereby worsening the CBF deficit. Therefore, rapid nontranscriptional upregulation of eNOS activity by small molecule inhibitors of Rho-kinase may be a viable therapeutic approach in acute stroke.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17033691      PMCID: PMC2614438          DOI: 10.1038/sj.jcbfm.9600406

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  37 in total

1.  Actin microfilament disrupters enhance K(ATP) channel opening in patches from guinea-pig cardiomyocytes.

Authors:  A Terzic; Y Kurachi
Journal:  J Physiol       Date:  1996-04-15       Impact factor: 5.182

2.  Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine.

Authors:  Z Huang; P L Huang; J Ma; W Meng; C Ayata; M C Fishman; M A Moskowitz
Journal:  J Cereb Blood Flow Metab       Date:  1996-09       Impact factor: 6.200

3.  Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen.

Authors:  J K Liao; J J Zulueta; F S Yu; H B Peng; C G Cote; P M Hassoun
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

4.  Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)

Authors:  K Kimura; M Ito; M Amano; K Chihara; Y Fukata; M Nakafuku; B Yamamori; J Feng; T Nakano; K Okawa; A Iwamatsu; K Kaibuchi
Journal:  Science       Date:  1996-07-12       Impact factor: 47.728

5.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase.

Authors:  P L Huang; Z Huang; H Mashimo; K D Bloch; M A Moskowitz; J A Bevan; M C Fishman
Journal:  Nature       Date:  1995-09-21       Impact factor: 49.962

6.  Neuroprotective properties of a protein kinase inhibitor against ischaemia-induced neuronal damage in rats and gerbils.

Authors:  S Satoh; I Ikegaki; Y Suzuki; T Asano; M Shibuya; H Hidaka
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

7.  Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase.

Authors:  Karen A Fagan; Masahiko Oka; Natalie R Bauer; Sarah A Gebb; D Dunbar Ivy; Kenneth G Morris; Ivan F McMurtry
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-02-20       Impact factor: 5.464

8.  Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection.

Authors:  Sebastian Wolfrum; Andreas Dendorfer; Yoshiyuki Rikitake; Timothy J Stalker; Yulan Gong; Rosario Scalia; Peter Dominiak; James K Liao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-08-19       Impact factor: 8.311

9.  Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia.

Authors:  F Zhang; J G White; C Iadecola
Journal:  J Cereb Blood Flow Metab       Date:  1994-03       Impact factor: 6.200

10.  Inhibition by the protein kinase inhibitor HA1077 of the activation of NADPH oxidase in human neutrophils.

Authors:  M Arai; Y Sasaki; R Nozawa
Journal:  Biochem Pharmacol       Date:  1993-10-19       Impact factor: 5.858

View more
  53 in total

1.  Fingolimod provides long-term protection in rodent models of cerebral ischemia.

Authors:  Ying Wei; Muge Yemisci; Hyung-Hwan Kim; Lai Ming Yung; Hwa Kyoung Shin; Seo-Kyoung Hwang; Shuzhen Guo; Tao Qin; Nafiseh Alsharif; Volker Brinkmann; James K Liao; Eng H Lo; Christian Waeber
Journal:  Ann Neurol       Date:  2010-11-12       Impact factor: 10.422

Review 2.  Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2.

Authors:  Federico Carbone; Priscila Camillo Teixeira; Vincent Braunersreuther; François Mach; Nicolas Vuilleumier; Fabrizio Montecucco
Journal:  Antioxid Redox Signal       Date:  2014-04-22       Impact factor: 8.401

Review 3.  Role of endothelial nitric oxide in cerebrovascular regulation.

Authors:  Dmitriy N Atochin; Paul L Huang
Journal:  Curr Pharm Biotechnol       Date:  2011-09       Impact factor: 2.837

Review 4.  NADPH oxidases as therapeutic targets in ischemic stroke.

Authors:  Timo Kahles; Ralf P Brandes
Journal:  Cell Mol Life Sci       Date:  2012-05-23       Impact factor: 9.261

Review 5.  Role of Nitric Oxide and Hydrogen Sulfide in Ischemic Stroke and the Emergent Epigenetic Underpinnings.

Authors:  Parimala Narne; Vimal Pandey; Prakash Babu Phanithi
Journal:  Mol Neurobiol       Date:  2018-06-20       Impact factor: 5.590

6.  Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice.

Authors:  K A Jackman; A A Miller; T M De Silva; P J Crack; G R Drummond; C G Sobey
Journal:  Br J Pharmacol       Date:  2009-01-23       Impact factor: 8.739

Review 7.  Optical brain imaging in vivo: techniques and applications from animal to man.

Authors:  Elizabeth M C Hillman
Journal:  J Biomed Opt       Date:  2007 Sep-Oct       Impact factor: 3.170

8.  Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage.

Authors:  Jens P Dreier; Sebastian Major; Andrew Manning; Johannes Woitzik; Chistoph Drenckhahn; Jens Steinbrink; Christos Tolias; Ana I Oliveira-Ferreira; Martin Fabricius; Jed A Hartings; Peter Vajkoczy; Martin Lauritzen; Ulrich Dirnagl; Georg Bohner; Anthony J Strong
Journal:  Brain       Date:  2009-05-06       Impact factor: 13.501

9.  Hyperlipidemia disrupts cerebrovascular reflexes and worsens ischemic perfusion defect.

Authors:  Cenk Ayata; Hwa Kyoung Shin; Ergin Dileköz; Dmitriy N Atochin; Satoshi Kashiwagi; Katharina Eikermann-Haerter; Paul L Huang
Journal:  J Cereb Blood Flow Metab       Date:  2013-03-13       Impact factor: 6.200

10.  Rho-kinase inhibition improves ischemic perfusion deficit in hyperlipidemic mice.

Authors:  Hwa Kyoung Shin; Paul L Huang; Cenk Ayata
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-06       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.